Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation

被引:71
作者
Miwa, Yuko [1 ,8 ]
Yamamoto, Koji [7 ]
Onishi, Akira [2 ]
Iwamoto, Masaki [2 ,3 ]
Yazaki, Satoko [2 ,3 ]
Haneda, Masataka [1 ]
Iwasaki, Kenta [1 ]
Liu, DaGe [1 ]
Ogawa, Haruko [4 ]
Nagasaka, Takaharu [5 ]
Uchida, Kazuharu [5 ]
Nakao, Akimasa [6 ]
Kadomatsu, Kenji [8 ]
Kobayashi, Takaaki [1 ,6 ]
机构
[1] Nagoya Univ, Sch Med, Dept Appl Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Natl Inst Agrobiol Sci, Dept Dev Biol, Tsukuba, Ibaraki, Japan
[3] Prime Tech Ltd, Tsuchiura, Ibaraki, Japan
[4] Obihiro Univ Agr & Vet Med, Res Ctr Anim Hyg & Food Safety, Obihiro, Hokkaido 080, Japan
[5] Nagoya Daini Red Cross Hosp, Dept Transplant Surg, Nagoya, Aichi, Japan
[6] Nagoya Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4668550, Japan
[7] Nagoya Univ, Sch Med, Dept Transfus Med, Nagoya, Aichi 4668550, Japan
[8] Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan
基金
日本学术振兴会;
关键词
coagulation disorder; decay accelerating factor; gene transfer; thrombomodulin; xenotransplantation; ACTIVATED PROTEIN-C; RECOMBINANT HUMAN ANTITHROMBIN; AORTIC ENDOTHELIAL-CELLS; TISSUE FACTOR ACTIVITY; BETA-GALACTOSIDASE-C; GENE-KNOCKOUT PIGS; FACTOR-V; HEART-TRANSPLANTATION; HYPERACUTE REJECTION; XENOGRAFT REJECTION;
D O I
10.1111/j.1399-3089.2009.00555.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background: Problems of coagulation disorder remain to be resolved in pig-to-primate xenotransplantation. Molecular incompatibilities in the coagulation systems between pigs and humans, such as the thrombomodulin (TM)-protein C system or direct prothrombinase activity, have been suggested as possible causes. Coagulation and complement activation are closely related to each other. The purpose of this study was to elucidate the protective effects on the coagulation system of the expression of human TM and decay accelerating factor (hDAF) (for inhibition of complement activation) in pig endothelial cells. Methods: Human aortic endothelial cells (HAEC), porcine aortic endothelial cells (PAEC), hDAF-expressing PAEC (hDAF-PAEC), hDAF/Endo-beta-galactosidase C-expressing PAEC (hDAF/EndoGalC-PAEC), hTM-expressing PAEC (hTM-PAEC), hDAF/hTM expressing-PAEC (hDAF/hTM-PAEC), and hDAF/EndoGalC/hTM-expressing PAEC (hDAF/EndoGalC/hTM-PAEC) were used in this study. Coagulation activity was examined by clotting, activated protein C (APC), and thrombin generation assay. Results: A large difference was observed in clotting time of human plasma when exposed to PAEC (170 s) and HAEC (1020 s). hTM expression on PAEC was proven to produce a comparable level of APC to that produced by HAEC, which prolonged the clotting time, though not to the level of HAEC. Pretreatment with human sera considerably shortened the clotting time in PAEC (80 s). hDAF-PAEC significantly inhibited such a shortening of clotting time by reductions in tissue factor expression and thrombin generation. Thrombin generation through direct prothrombinase activity, which was detected only in PAEC, could be suppressed by hTM expression. Suppression of antibody binding and complement activation improved clotting time not in PAEC, but in PAEC expressing hTM. Conclusions: In addition to effective suppression of antibody-induced complement activation, hTM expression in PAEC may be essential for regulating procoagulant activity in xenotransplantation.
引用
收藏
页码:26 / 37
页数:12
相关论文
共 53 条
[1]
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism [J].
Abeyama, K ;
Stern, DM ;
Ito, Y ;
Kawahara, K ;
Yoshimoto, Y ;
Tanaka, M ;
Uchimura, T ;
Ida, N ;
Yamazaki, Y ;
Yamada, S ;
Yamamoto, Y ;
Yamamoto, H ;
Iino, S ;
Taniguchi, N ;
Maruyama, I .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1267-1274
[2]
Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates [J].
Adams, DH ;
Kadner, A ;
Chen, RH ;
Farivar, RS .
XENOTRANSPLANTATION, 2001, 8 (01) :36-40
[3]
Ayares D, 2007, XENOTRANSPLANTATION, V14, P428
[4]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]
Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban [J].
Brandl, Ulrike ;
Joeckle, Hannah ;
Erhardt, Matthias ;
Michel, Sebastian ;
Burdorf, Lars ;
Brenner, Paolo ;
Bittmann, Iris ;
Roessle, Matthias ;
Mordstein, Volker ;
Hammer, Claus ;
Thein, Eckart ;
Reichart, Bruno ;
Schmoeckel, Michael .
TRANSPLANTATION, 2007, 84 (12) :1667-1676
[6]
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation [J].
Cabric, Sanja ;
Sanchez, Javier ;
Lundgren, Torbjorn ;
Foss, Aksel ;
Felldin, Marie ;
Kallen, Ragnar ;
Salmela, Kaija ;
Tibell, Annika ;
Tufveson, Gunnar ;
Larsson, Rolf ;
Korsgren, Olle ;
Nilsson, Bo .
DIABETES, 2007, 56 (08) :2008-2015
[7]
Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity [J].
Chan, CWY ;
Chan, MWC ;
Liu, MF ;
Fung, L ;
Cole, EH ;
Leibowitz, JL ;
Marsden, PA ;
Clark, DA ;
Levy, GA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :5170-5177
[8]
Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins [J].
Chen, DX ;
Riesbeck, K ;
Kemball-Cook, G ;
McVey, JH ;
Tuddenham, EGD ;
Lechler, RI ;
Dorling, A .
TRANSPLANTATION, 1999, 67 (03) :467-474
[9]
Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium [J].
Chen, DX ;
Weber, M ;
McVey, JH ;
Kemball-Cook, G ;
Tuddenham, EGD ;
Lechler, RI ;
Dorling, A .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :1958-1963
[10]
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways [J].
Conway, EM ;
Van de Wouwer, M ;
Pollefeyt, S ;
Jurk, K ;
Van Aken, H ;
De Vriese, A ;
Weitz, JI ;
Weiler, H ;
Hellings, PW ;
Schaeffer, P ;
Herbert, JM ;
Collen, D ;
Theilmeier, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (05) :565-577